Sinovac Biotech Ltd.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000D0D8P5
SVA
Sinovac Biotech Ltd.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Sinovac Biotech Ltd.
ISIN
AGP8696W1045
TICKER
SVA
MIC
XNAS
REUTERS
SVA.OQ
BLOOMBERG
SVA US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Fri, 16.08.2024
Sinovac
AGP8696W1045
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2024.
First Half of 2024 Financial Summary
Sales for the six months ended June 30, 2024 were $121.3 million, compared to $140.4 million in...
Sinovac
Information on product placements
